These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19456219)

  • 1. Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.
    Johnatty SE; Beesley J; Chen X; Spurdle AB; Defazio A; Webb PM; ; ; Goode EL; Rider DN; Vierkant RA; Anderson S; Wu AH; Pike M; Van Den Berg D; Moysich K; Ness R; Doherty J; Rossing MA; Pearce CL; Chenevix-Trench G
    Twin Res Hum Genet; 2009 Jun; 12(3):269-75. PubMed ID: 19456219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome.
    Meng QH; Xu E; Hildebrandt MA; Liang D; Lu K; Ye Y; Wagar EA; Wu X
    Clin Chem; 2014 Jan; 60(1):222-32. PubMed ID: 24146310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.
    Schildkraut JM; Iversen ES; Wilson MA; Clyde MA; Moorman PG; Palmieri RT; Whitaker R; Bentley RC; Marks JR; Berchuck A
    PLoS One; 2010 Apr; 5(4):e10061. PubMed ID: 20386703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma.
    Kim SS; Eun JW; Cho HJ; Lee HY; Seo CW; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
    Anticancer Res; 2019 Apr; 39(4):2217-2226. PubMed ID: 30952770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of a short peptide on p53-null SKOV3 ovarian cancer cells.
    Huang YS; Wang TX; Lin XM; Wang H; Li RZ; Zeng X; Zhu C; Chen LK; Guo Q; Liu H; Wu XP
    Anticancer Drugs; 2019 Nov; 30(10):973-982. PubMed ID: 31503014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STK15 polymorphisms and association with risk of invasive ovarian cancer.
    Dicioccio RA; Song H; Waterfall C; Kimura MT; Nagase H; McGuire V; Hogdall E; Shah MN; Luben RN; Easton DF; Jacobs IJ; Ponder BA; Whittemore AS; Gayther SA; Pharoah PD; Kruger-Kjaer S
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1589-94. PubMed ID: 15466974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between genetic polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women.
    Kang S; Li SZ; Wang N; Zhou RM; Wang T; Wang DJ; Li XF; Bui J; Li Y
    Hum Reprod; 2010 Jul; 25(7):1806-11. PubMed ID: 20504870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF1 and FGF2 mutations in preeclampsia and related features.
    Marwa BA; Raguema N; Zitouni H; Feten HB; Olfa K; Elfeleh R; Almawi W; Mahjoub T
    Placenta; 2016 Jul; 43():81-5. PubMed ID: 27324104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between microRNA binding site SNPs in FGFs and FGFRs and the risk of non-syndromic orofacial cleft.
    Li D; Zhang H; Ma L; Han Y; Xu M; Wang Z; Jiang H; Zhang W; Wang L; Pan Y
    Sci Rep; 2016 Aug; 6():31054. PubMed ID: 27511275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
    Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility.
    Yang CQ; Chan KY; Ngan HY; Khoo US; Chiu PM; Chan QK; Xue WC; Cheung AN
    Carcinogenesis; 2006 Jul; 27(7):1502-6. PubMed ID: 16574671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
    Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
    Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
    Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
    Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer.
    Webb PM; Ibiebele TI; Hughes MC; Beesley J; van der Pols JC; Chen X; Nagle CM; Bain CJ; Chenevix-Trench G; ;
    Eur J Clin Nutr; 2011 Oct; 65(10):1133-40. PubMed ID: 21629268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
    Permuth-Wey J; Fulp WJ; Reid BM; Chen Z; Georgeades C; Cheng JQ; Magliocco A; Chen DT; Lancaster JM
    Int J Cancer; 2016 Feb; 138(3):612-9. PubMed ID: 26264211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic fibroblast growth factor and receptor expression in human ovarian cancer.
    Crickard K; Gross JL; Crickard U; Yoonessi M; Lele S; Herblin WF; Eidsvoog K
    Gynecol Oncol; 1994 Nov; 55(2):277-84. PubMed ID: 7959296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
    Schildkraut JM; Goode EL; Clyde MA; Iversen ES; Moorman PG; Berchuck A; Marks JR; Lissowska J; Brinton L; Peplonska B; Cunningham JM; Vierkant RA; Rider DN; Chenevix-Trench G; Webb PM; Beesley J; Chen X; Phelan C; Sutphen R; Sellers TA; Pearce L; Wu AH; Van Den Berg D; Conti D; Elund CK; Anderson R; Goodman MT; Lurie G; Carney ME; Thompson PJ; Gayther SA; Ramus SJ; Jacobs I; Krüger Kjaer S; Hogdall E; Blaakaer J; Hogdall C; Easton DF; Song H; Pharoah PD; Whittemore AS; McGuire V; Quaye L; Anton-Culver H; Ziogas A; Terry KL; Cramer DW; Hankinson SE; Tworoger SS; Calingaert B; Chanock S; Sherman M; Garcia-Closas M;
    Cancer Res; 2009 Mar; 69(6):2349-57. PubMed ID: 19276375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of bovine fibroblast growth factor 2 (FGF2) gene with milk fat and productive life: an example of the ability of the candidate pathway strategy to identify quantitative trait genes.
    Wang X; Maltecca C; Tal-Stein R; Lipkin E; Khatib H
    J Dairy Sci; 2008 Jun; 91(6):2475-80. PubMed ID: 18487671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
    Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis.
    Butt C; Lim S; Greenwood C; Rahman P
    BMC Musculoskelet Disord; 2007 Jan; 8():1. PubMed ID: 17204151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.